Trials / Completed
CompletedNCT00151814
Olmesartan Pediatric Pharmacokinetic (PK) Study
An Open-label Study of the Single-dose Pharmacokinetics of Olmesartan Medoxomil in Pediatric Patients With Hypertension
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Daiichi Sankyo · Industry
- Sex
- All
- Age
- 12 Months – 16 Years
- Healthy volunteers
- Not accepted
Summary
Determine single dose pharmacokinetic parameters of olmesartan in pediatric patients with hypertension in ages 12 months - 16 years
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Olmesartan medoxomil | Children less than 6 years old: oral suspension or tablets equal to 0.3 mg/kg; 20 mg or 40 mg tablets for older children depending on weight. |
Timeline
- Start date
- 2005-09-01
- Primary completion
- 2008-02-01
- Completion
- 2008-02-01
- First posted
- 2005-09-09
- Last updated
- 2010-04-15
- Results posted
- 2010-04-09
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00151814. Inclusion in this directory is not an endorsement.